News

As part of the collaboration, Lorus will test the anticancer activity and drug-like properties of pancratistatin derivatives synthesized by Dr. Tomas Hudlicky”s research group at Brock University. Lorus

The multi-centre, randomised study will evaluate the efficacy and safety of two different doses of Nefecon, an enteric formulation of a locally acting corticosteroid. Primary objective of the

Under the agreement, WuXi will provide JV with clinical and regulatory services from its China-based clinical organization as well as supply laboratory services through a preferred provider arrangement.

The patent entitled ‘ Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein’ covers the company’s oral delivery nanotechnology, designed for improving the oral bioavailability of macromolecules like insulin. Aphios

The FDA approved, once-daily, oral product is indicated for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linzess was designed to act locally

As part of the agreement, SSB will globally market and distribute complete Umetrics portfolio for the pharmaceutical and biopharmaceutical industries as well as integrate Umetrics software programs as

Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the Gliminsand, and is being developed through phase II trials as a monotherapy and as an add-on therapy

Abacavir, the generic version of ViiV Healthcare Company’s Ziagen Tablets 300mg, is used to treat HIV infected adults and children as a part of antiretroviral (ARV) combination therapy.

Mylan has commenced shipping the generic medication that is indicated only to treat uncomplicated Plasmodium falciparum malaria. The antimalarial medication works by inhibiting nucleic acid synthesis, protein synthesis